A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
PHASE2
GSK2140944 has demonstrated in vitro activity against Neisseria (N.) gonorr...
Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
PHASE2
GSK2140944 belongs to a novel structural class of antibiotics - Bacterial T...
A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects
PHASE1
This is an open-label, non-randomized, two-period, cross-over, mass balance...